PROK2 and colitis: In these models, therapy resistance occurred only upon the induction of an inflammatory state by chemically-induced colitis, which caused the augmentation of the G-CSF serum levels in mice, followed by the recruitment of neutrophils into the tumor stroma and the release of Bv8/PROK2, promoting angiogenesis.